Document Detail


Functional interaction of Ugene and EBV infection mediates tumorigenic effects.
MedLine Citation:
PMID:  21317926     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Epstein-Barr virus (EBV) infection is associated with many human neoplasms, in which EBV-derived latent membrane protein-1 (LMP1) appears to be critical, but its exact oncogenic mechanism remains to be defined. To this end, our initial microarray analyses identified a LMP1-inducible gene, Ugene, originally characterized as a binding partner for uracil DNA glycosylase 2, which is highly expressed in malignant colon cancer. In this report, it was found that Ugene, designated herein as LMP1-induced protein (LMPIP), was induced, in a time-dependent manner, in EBV-infected peripheral blood mononuclear cells and LMP1-transfected 293 cells. Functionally, when compared with mock-transfected cells, overexpression of LMPIP in nasopharyngeal carcinoma (NPC) cell lines resulted in a decrease in reactive oxygen species production and maintained mitochondria membrane potential (Δψ) loss induced by H(2)O(2). The NPC cells transfected with LMPIP also showed a decrease in G1 population and an increase in the cell population in sub-G1 and multiploid phase, concomitant with increased levels of cell cycle activators, including cyclin D1 and CDK4. In contrast, silencing of LMPIP expression in the NPC tumor cell lines with short hairpin RNA interference revealed significantly decreased cell population at G1/S phase, while the number of cells in multiploid phase increased. Significantly, NPC cells with LMPIP knock-down also showed a decrease in tumorigenic and transforming activity induced by ectopic LMP1 expression, as determined by analyses of soft agar foci and tumor size in nude mice. Further, elevated LMPIP expression was also noted in cytoplasm and nuclei in EBV-infected NPC tumor cell mass and non-EBV-infected tumor cell lines. These results suggested that LMPIP may have an important mediator role in EBV-mediated neoplasm and may serve as a new target for therapy of tumors induced by EBV infection.Oncogene advance online publication, 14 February 2011; doi:10.1038/onc.2011.16.
Authors:
L-T Wang; C-S Lin; C-Y Chai; K-Y Liu; J-Y Chen; S-H Hsu
Related Documents :
12646586 - Expression of the telomeric repeat binding factor gene ngtrf1 is closely coordinated wi...
2457616 - T cell-mediated recognition of foreign antigen and the ia molecule observed by stopped-...
4077716 - Age related changes in cellularity, mitotic activity and pyknotic cell number in the mo...
11976216 - Frequent intracellular clonal expansions of somatic mtdna mutations: significance and m...
3019076 - Incipient germ cell tumor in sertoli-cell-only syndrome testis, accompanied with retrop...
20202196 - Morphologic characterization of osteosarcoma growth on the chick chorioallantoic membrane.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-2-14
Journal Detail:
Title:  Oncogene     Volume:  -     ISSN:  1476-5594     ISO Abbreviation:  -     Publication Date:  2011 Feb 
Date Detail:
Created Date:  2011-2-14     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8711562     Medline TA:  Oncogene     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The Hippo pathway transcriptional co-activator, YAP, is an ovarian cancer oncogene.
Next Document:  MicroRNA-21 targets tumor suppressor genes ANP32A and SMARCA4.